Asset Details
MbrlCatalogueTitleDetail
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
/ Albuminuria - prevention & control
/ Cardiovascular Diseases - etiology
/ Cardiovascular Diseases - prevention & control
/ Comparative Effectiveness Research
/ Death
/ Diabetes
/ Diabetes Complications - etiology
/ Diabetes Complications - prevention & control
/ Diabetes mellitus (non-insulin dependent)
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetic Neuropathies - diagnosis
/ Diabetic Neuropathies - etiology
/ Diabetic Neuropathies - prevention & control
/ Dyslipidemias - prevention & control
/ Glucose
/ Glycated Hemoglobin - analysis
/ Heart Failure - prevention & control
/ Humans
/ Hypertension - prevention & control
/ Hypoglycemic Agents - adverse effects
/ Hypoglycemic Agents - therapeutic use
/ Insulin
/ Insulin Glargine - adverse effects
/ Insulin Glargine - therapeutic use
/ Liraglutide - adverse effects
/ Liraglutide - therapeutic use
/ Outpatient-Based Clinical Medicine
/ Sitagliptin Phosphate - adverse effects
/ Sitagliptin Phosphate - therapeutic use